Concepedia

Andrew Prongay

AP

Statistics

Publications

44

Citations

2.9K

H-Index

27

Active since

1989

Affiliations

AIL Research (United States)(Current)

University of Michigan

Andrew Prongay is an author at AIL Research (United States) specializing in medicinal chemistry, life sciences, and molecular virology.

Publications per year

1989–2023

44

Publications

44

Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation.

Thierry Fischmann, Alan Hruza, Xiao Da Niu et al. · Nature Structural Biology · 1999 · 456 citations

, , +10

Crystal structure of dimeric HIV-1 capsid protein

Cory Momany, Ladislau C. Kovari, Andrew Prongay et al. · Nature Structural & Molecular Biology · 1996 · 322 citations

, , +14

SCH 503034, a Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease, Suppresses Polyprotein Maturation and Enhances the Antiviral Activity of Alpha Interferon in Replicon Cells

Bruce A. Malcolm, R. Liu, Frederick Lahser et al. · Antimicrobial Agents and Chemotherapy · 2006 · 318 citations · Full text

, , +17

Discovery of (1 <i>R</i> ,5 <i>S</i> )- <i>N</i> -[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2( <i>S</i> )-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2( <i>S</i> )-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor:  A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection

Srikanth Venkatraman, Stéphane Bogen, Ashok Arasappan et al. · Journal of Medicinal Chemistry · 2006 · 282 citations · Full text

, , +17

Characterization of resistance mutations against HCV ketoamide protease inhibitors

Xinchun Tong, Stéphane Bogen, Robert A. Chase et al. · Antiviral Research · 2008 · 127 citations

, , +14

1–5 of 44